Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NUVB
DateTimeSourceHeadlineSymbolCompany
30/05/202406:05Business WireNuvation Bio to Present at the Jefferies Global Healthcare ConferenceNYSE:NUVBPanacea Acquisition Corp
25/05/202407:22Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNYSE:NUVBPanacea Acquisition Corp
25/05/202406:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:NUVBPanacea Acquisition Corp
15/05/202406:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
15/05/202406:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
15/05/202406:20Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
15/05/202406:05Business WireNuvation Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
25/04/202400:01Business WireNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:NUVBPanacea Acquisition Corp
11/04/202406:01Business WireNuvation Bio Completes Acquisition of AnHeart TherapeuticsNYSE:NUVBPanacea Acquisition Corp
28/03/202423:00Business WireNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerNYSE:NUVBPanacea Acquisition Corp
25/03/202422:00Business WireNuvation Bio to Acquire AnHeart Therapeutics in All-Stock TransactionNYSE:NUVBPanacea Acquisition Corp
15/03/202407:05Business WireNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
05/03/202409:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NUVBPanacea Acquisition Corp
05/03/202409:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
05/03/202408:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
05/03/202408:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
01/03/202409:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:NUVBPanacea Acquisition Corp
01/03/202408:48Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
01/03/202408:01Business WireNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
11/01/202408:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
11/01/202408:21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
09/01/202408:58Dow Jones NewsNuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor TreatmentNYSE:NUVBPanacea Acquisition Corp
09/01/202408:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
09/01/202408:10Business WireNuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of DirectorsNYSE:NUVBPanacea Acquisition Corp
09/01/202408:05Business WireNuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
15/12/202308:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
28/11/202308:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
28/11/202308:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
14/11/202308:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
14/11/202308:05Business WireNuvation Bio Announces Departure of Chief Financial OfficerNYSE:NUVBPanacea Acquisition Corp
 Showing the most relevant articles for your search:NYSE:NUVB

Your Recent History

Delayed Upgrade Clock